Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Formaat: Artigo
Taal:Russo
Gepubliceerd in: «FIRMA «SILICEA» LLC 2004-12-01
Reeks:Российский кардиологический журнал
Onderwerpen:
arterial hypertension
metabolic syndrome
cardioprotective effects
rilmenidine
Online toegang:https://russjcardiol.elpub.ru/jour/article/view/2326
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items